{
  "url": "https://openlegislation.uk/medicines-products-for-human-use-fees-regulations-2012/regulation-3",
  "json_url": "https://openlegislation.uk/medicines-products-for-human-use-fees-regulations-2012/regulation-3.json",
  "legislation": "nisr/2012/134",
  "legislation_title": "The Medicines (Products for Human Use) (Fees) Regulations 2012",
  "legislation_url": "https://openlegislation.uk/medicines-products-for-human-use-fees-regulations-2012",
  "path": "regulation/3",
  "kind": "regulation",
  "number": "3",
  "heading": "Interpretation of Part 2",
  "text": "In this Part—\n“EU marketing authorization” means—\n(a) a United Kingdom marketing authorization granted by the licensing authority under the Marketing Authorisation Regulations;\n(b) a marketing authorization granted by the competent authority of an EEA State other than the United Kingdom in accordance with the 2001 Directive; or\n(c) a European Union marketing authorization; and\n“relevant medicinal product” means a medicinal product for human use to which the provisions of the 2001 Directive apply.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/nisr/2012/134/regulation/3",
    "retrieved_at": "2026-10-29T01:16:38.443269+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}